Cite
Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?
MLA
Hermida, Alexis, et al. “Type 3 Long QT Syndrome: Is the Effectiveness of Treatment with Beta-Blockers Population-Specific?” Heart Rhythm, vol. 21, no. 3, Mar. 2024, pp. 313–20. EBSCOhost, https://doi.org/10.1016/j.hrthm.2023.11.007.
APA
Hermida, A., Gourraud, J.-B., Denjoy, I., Fressart, V., Kyndt, F., Maltret, A., Khraiche, D., Klug, D., Mabo, P., Sacher, F., Maury, P., Winum, P., Defaye, P., Clerici, G., Babuty, D., Elbez, Y., Morgat, C., Surget, E., Messali, A., … Extramiana, F. (2024). Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific? Heart Rhythm, 21(3), 313–320. https://doi.org/10.1016/j.hrthm.2023.11.007
Chicago
Hermida, Alexis, Jean-Baptiste Gourraud, Isabelle Denjoy, Véronique Fressart, Florence Kyndt, Alice Maltret, Diala Khraiche, et al. 2024. “Type 3 Long QT Syndrome: Is the Effectiveness of Treatment with Beta-Blockers Population-Specific?” Heart Rhythm 21 (3): 313–20. doi:10.1016/j.hrthm.2023.11.007.